DNA Biomed (Israel) Today
| DNA Stock | ILS 88.60 1.60 1.84% |
Performance10 of 100
| Odds Of DistressLess than 33
|
DNA Biomed is trading at 88.60 as of the 25th of November 2024, a 1.84 percent up since the beginning of the trading day. The stock's open price was 87.0. DNA Biomed has about a 33 percent probability of financial distress in the next few years of operation but had a somewhat ok performance during the last 90 days. Equity ratings for DNA Biomed Solns are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of May 2023 and ending today, the 25th of November 2024. Click here to learn more.
D.N.A Biomedical Solutions Ltd. develops and commercializes laser spectrometry-based trace detection systems in Israel. D.N.A Biomedical Solutions Ltd. was founded in 2004 and is based in Ramat Gan, Israel. D N operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.. The company has 123.16 M outstanding shares. More on DNA Biomed Solns
Moving against DNA Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
DNA Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. DNA Biomed's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding DNA Biomed or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Vice President - Finance | Tony Klein |
| Business Concentration | Information Technology, Electronic Equipment, Instruments & Components, Biotechnology, Healthcare (View all Sectors) |
DNA Biomed Solns (DNA) is traded on Tel Aviv Stock Exchange in Israel and employs 11 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 86.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate DNA Biomed's market, we take the total number of its shares issued and multiply it by DNA Biomed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. DNA Biomed Solns operates under Electronic Equipment, Instruments & Components sector and is part of Information Technology industry. The entity has 123.16 M outstanding shares.
DNA Biomed Solns has accumulated about 492 K in cash with (2.33 M) of positive cash flow from operations.
Check DNA Biomed Probability Of Bankruptcy
Ownership AllocationDNA Biomed Solns secures a total of 123.16 Million outstanding shares. DNA Biomed Solns shows considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check DNA Ownership Details
DNA Biomed Solns Risk Profiles
Although DNA Biomed's alpha and beta are two of the key measurements used to evaluate DNA Biomed's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.46 | |||
| Semi Deviation | 3.26 | |||
| Standard Deviation | 4.58 | |||
| Variance | 20.95 |
DNA Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in DNA Biomed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Other Information on Investing in DNA Stock
DNA Biomed financial ratios help investors to determine whether DNA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DNA with respect to the benefits of owning DNA Biomed security.